Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.
about
PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical applicationLung cancer-initiating cells: a novel target for cancer therapyA meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancerJudicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and PerspectivesCXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.Downregulation of UHRF1 increases tumor malignancy by activating the CXCR4/AKT-JNK/IL-6/Snail signaling axis in hepatocellular carcinoma cells.Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinomaAiolos promotes anchorage independence by silencing p66Shc transcription in cancer cells.Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer.Epigenetic silencing of CXCR4 promotes loss of cell adhesion in cervical cancer.Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer.ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxisCancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations.The intricate role of CXCR4 in cancer.Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatinTargeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.An important role for peroxiredoxin II in survival of A549 lung cancer cells resistant to gefitinib.Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer.The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells.Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancerMucin 1-mediated chemo-resistance in lung cancer cells.Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer.CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential.Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics.Chemokines and their receptors in lung cancer progression and metastasis.COPD promotes migration of A549 lung cancer cells: the role of chemokine CCL21.Brain tumor stem cell multipotency correlates with nanog expression and extent of passaging in human glioblastoma xenografts.Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancerEmerging targets in cancer management: role of the CXCL12/CXCR4 axis.Antiangiogenic therapy using endostatin increases the number of ALDH+ lung cancer stem cells by generating intratumor hypoxia.BIS-mediated STAT3 stabilization regulates glioblastoma stem cell-like phenotypes.Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor.Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer.Genetics of breast cancer bone metastasis: a sequential multistep pattern.CXCR4 as biomarker for radioresistant cancer stem cells.CXCL12-CXCR4 contributes to the implication of bone marrow in cancer metastasis.
P2860
Q26801538-05D7A581-2EAC-40E4-A8BD-AB280D81E233Q26824222-1211CDB7-EDE2-4673-8406-52F04F15D6EEQ26998677-3CC92802-12F1-4D06-B0E3-2384F56128FFQ28071388-00695E85-35D9-426E-95C9-65D84AA36D22Q33677057-FB301577-3B81-47BC-A151-EF4F7F7BB9A0Q33765984-A2C1F2E9-68B5-43C1-8DE3-EE99740D77EBQ33775283-C429722D-EEEC-4E7A-9E5A-2541AFA1CB45Q33806421-AC99477E-3334-405C-89FE-464C8EDBC700Q33814898-D71ABF8F-BEA4-46ED-9B57-15CB0BD2D32EQ33993996-3C84F95D-4C4B-4906-8349-DD501DC0C84FQ34179827-E9ACA2E1-5C35-40DF-89BD-FFC78328091CQ34978368-21CA8BF3-B149-448F-B7A0-49BDE6828084Q34998443-B3381CF3-7E8E-4D32-8E46-6C331D1CDC11Q35067624-FDF5DB07-A434-4080-8C1E-C78AAF18C204Q35175999-A2BFB1F9-9065-418B-9BA5-7064EBF4F791Q35213463-DB7970C2-641F-4AA2-8856-EEF53BA81146Q35681515-48E33EB2-C423-46F8-A10F-1185E76AC0EEQ35759218-94901312-7A08-4481-8203-407819C0C945Q35787278-EE3DA9E5-7193-4671-8D01-C89176AA3E96Q35833023-01227321-8BC9-4BFB-A4EE-807E8FAA614DQ36144732-B8E464AA-FAE0-4A73-924C-A934A6DB4E74Q36293646-026269A3-95AF-42B6-8199-C79EBC37B477Q36507586-3D789926-9B03-4378-87AA-2E52554A25AFQ36567573-65864FFD-4FFE-40D2-A058-98239094E6A8Q36583985-A00A66E9-4EA6-4B11-AB00-3CE4A9BC956DQ36688108-440123E2-BDF9-4D0D-8373-38292416ADF5Q36906094-B3EAC1B5-884B-444E-8555-D6A70B630E0EQ36955681-C38EA6A1-8325-411E-830C-1B5719385B9CQ37093560-C96F7535-BAD1-4952-B7AA-F356E123AB8FQ37099888-40B38107-3B39-41DF-B342-E4F0C76471FDQ37225329-E4E22C68-AF53-4D2F-81B6-0252F6F10351Q37310622-7F9588D7-4777-41FF-A06C-2FAB692C0CEAQ37376452-32E72A44-0CBB-42A0-9B14-EF9E4CFD541CQ37525231-BB6E02F0-35BA-4C3E-B672-C83BDEFD9D9EQ37610799-B1EA7DAB-14C9-4632-851A-C5922E56B1D9Q37615286-14817609-D53C-44D1-8FD4-D4D93A654892Q37706915-F48ED5A9-A11E-4B20-AB8A-9997F79C248EQ38184928-7C0308DA-FB86-4E4D-9CDD-63812DFCAF95Q38197709-B559D11C-F3A5-4E92-84C7-C2EA6BB6A2D6Q38209604-FEADF87A-E5F0-4537-91AA-9D3FB3B2C127
P2860
Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Upregulation of CXCR4 is funct ...... -small cell lung cancer cells.
@en
Upregulation of CXCR4 is funct ...... -small cell lung cancer cells.
@nl
type
label
Upregulation of CXCR4 is funct ...... -small cell lung cancer cells.
@en
Upregulation of CXCR4 is funct ...... -small cell lung cancer cells.
@nl
prefLabel
Upregulation of CXCR4 is funct ...... -small cell lung cancer cells.
@en
Upregulation of CXCR4 is funct ...... -small cell lung cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Upregulation of CXCR4 is funct ...... -small cell lung cancer cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2012.37
P407
P577
2012-02-27T00:00:00Z